Image

Global Monogenic Disease Testing Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Monogenic Disease Testing Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Monogenic Disease Testing Market, By Test Type (Carrier Testing, Diagnostic Testing, New-Born Screening, Predictive and Pre-Symptomatic Testing, Prenatal Testing), Disease Type (Cystic fibrosis, Sickle Cell Anemia, Severe Combined Immunodeficiency (SCID), Tay-Sachs Disorder, Polycystic Kidney Disorder, Gaucher's Disease, Huntington's Disease, Neurofibromatosis, Thalassaemia, Familial Hypercholesterolemia), End Use (Hospitals, Ambulatory Surgical Centers, Specialized Clinics) – Industry Trends and Forecast to 2029.

Monogenic Disease Testing Market

Monogenic Disease Testing Market Analysis and Size

Preimplantation genetic testing for monogenic diseases (PGT-M) was introduced as a preventive test in assisted reproductive programmes for patients identified as having a high risk for inherited Mendelian conditions. A single gene mutation in a person's DNA sequence causes monogenic diseases. They can cause birth defects, intellectual, sensory or motor disability. These diseases have an impact on the quality of life and lifespan of those who are affected. Monogenic diseases, unfortunately, have no treatment or cure.

Data Bridge Market Research analyses that the monogenic disease testing market which is expected to reach at a CAGR of 11% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Monogenic Disease Testing Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Test Type (Carrier Testing, Diagnostic Testing, New-Born Screening, Predictive and Pre-Symptomatic Testing, Prenatal Testing), Disease Type (Cystic fibrosis, Sickle Cell Anemia, Severe Combined Immunodeficiency (SCID), Tay-Sachs Disorder, Polycystic Kidney Disorder, Gaucher's Disease, Huntington's Disease, Neurofibromatosis, Thalassaemia, Familial Hypercholesterolemia), End Use (Hospitals, Ambulatory Surgical Centers, Specialized Clinics)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Celera Support Services (U.S.), Abbott (U.S.), ELITech Group (U.S.), Quest Diagnostics Incorporated (U.S.), Auto Genomics (U.S.), PerkinElmer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.)

Market Opportunities

  • Rising prevalence of monogenic disorders

Market Definition

Monogenetic disorders are inherited due to a single defective gene on the autosomes, according to Mendel's Laws. Monogenic disorders are caused by a single mutated gene that can be found on either one or both chromosomes. This disorder affects both men and women equally, because of autosomal conditions. Cystic fibrosis, sickle cell anaemia, SCID, Tay-sachs disease, polycystic kidney disease, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia, and familial hypercholesterolemia are among the common monogenic disorders for which tests are available.

Global Monogenic Disease Testing Market Dynamics

Drivers

  • Rising monogenic disorders

The monogenic disorder is caused by a leucine for serine substitution at codon 810 of the MR. 15. This mutation changes the shape and specificity of the MR and eliminates the usual requirement for the 21-hydroxyl group of aldosterone to interact with the MR, which explains other steroids, such as progesterone, activate the MR and spironolactone, which is normally an antagonist of the MR, acts as an agonist in this disorder. All these are the factors which boost the growth of the market.

  • Increased usage of monogenic disease testing

The highly developed technological platforms and enhanced genomic tools are expected to have a significant impact on the monogenic disease testing market in the forecast period of 2022 to 2029. Another significant reason for the increased usage of monogenic disease testing has been the increased exclusive opportunity that require more research on monogenic disease tests.

Opportunities

  • Technological advancements

The rising prevalence of monogenic disorders around the world will provide ample opportunities for the growth of the monogenic disease testing market during the forecast period. For instance, CACNA1A (FHM1), which is located on chromosome 19p13 and codes for the 1 subunit of neuronal CaV2.1 (P/Q-type) voltage-gated calcium channels, was the first FHM gene discovered. These channels can be found all over the CNS. FHM has been linked to over 20 different missense mutations in this gene. Aside from hemiplegic migraine, these mutations are frequently linked to other phenotypes such as cerebellar ataxia and epilepsy.

Restraints/Challenges

  • Lack of trained professionals

Lack of trained professionals and dearth of knowledge, a false result can destroy a person's life and can even lead home to death ill obstruct the market's growth rate.

This monogenic disease testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the monogenic disease testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Monogenic Disease Testing Market Scope

The monogenic disease testing market is segmented on the basis of test type, disease type and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

  • Carrier Testing
  • Diagnostic Testing
  • New-Born Screening
  • Predictive and Pre-Symptomatic Testing
  • Prenatal Testing

 Disease Type

  • Cystic fibrosis
  • Sickle Cell Anemia
  • Severe Combined Immunodeficiency (SCID)
  • Tay-Sachs Disorder
  • Polycystic Kidney Disorder
  • Gaucher's Disease
  • Huntington's Disease
  • Neurofibromatosis
  • Thalassaemia
  • Familial Hypercholesterolemia

 End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

Monogenic Disease Testing Market Regional Analysis/Insights

The monogenic disease testing market is analysed and market size insights and trends are provided by country, test type, disease type and end use as referenced above.

The countries covered in the monogenic disease testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the monogenic disease testing market due to the high degree of intelligence and growing awareness amongst people regarding to the monogenic disease testing procedures.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the presence of a substantial number of organizations that are focusing on disease management.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The monogenic disease testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for monogenic disease testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the monogenic disease testing market. The data is available for historic period 2010-2020.

Competitive Landscape and Monogenic Disease Testing Market Share Analysis

The monogenic disease testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to monogenic disease testing market.

Some of the major players operating in the monogenic disease testing market are:

  • Celera Support Services (U.S.)
  • Abbott (U.S.)
  • ELITech Group (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • Auto Genomics (U.S.)
  • PerkinElmer Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The monogenic disease testing market is projected to grow at a CAGR of 11% during the forecast period of 2022-2029.
The factors such as the rising prevalence of monogenic disorders around the world will provide ample opportunities are the major growth driving factors.
The Monogenic Disease Testing Market is segmented by Test Type, Disease Type & End Use.
North America dominates the monogenic disease testing market due to the high degree of intelligence and growing awareness amongst people regarding to monogenic disease testing procedures.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the presence of a substantial number of organizations that are focusing on disease management.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials